RT @PDBrownOnc: PCI SCLC Review · LSSCLC brain MRI before PCI approx 1/4 have brain met! · HA-PCI efficacy unclear · Immuno may reduce brai…

Sharing a new online tool stratifying patients for pain flare and fracture after spine SBRT: Thank you so much to @sysbiodoubledoc, @dr_kmerrell, @MayoRadOnc, without whom this wouldn't be possible. Appreciate any feedback to keep improving the website!

Sharing a striking article about providing oncologic care amidst the war in Ukraine

@n_laack @PB_News Thank you so much for your mentorship and for sharing this, @n_laack. We hope this is the first of many more shipments! Anyone and everyone - please feel free to reach out if interested in working with us towards these goals

RT @KenOlivierMD: This week in RST I attended the Peace Rally downtown with dept friends and colleagues. Rabbi Werner read a beautiful pray…

RT @JAMANetworkOpen: Circulating tumor DNA (ctDNA) is a cost-effective and accurate post-treatment surveillance strategy for HPV-associated…

@lemmiwenks @MayoRadOnc @dr_kmerrell While it may be, multifraction treatments did not have lower rates of VCF in our analysis (Table 1). This could be an area for future study.

@jfcdrr @MayoRadOnc @jasonpsheehan @DanTrifMD Thanks - we looked at maximum dose for each of the individual SRS plans, and each showed an association with increased SRN and RN

@StephenRameyMD @MayoRadOnc @jasonpsheehan @DanTrifMD Thanks - we looked at each individual plan for the maximum dose and both the individual plans and the sum plan (when available) for V12

@jryckman3 @MayoRadOnc @jasonpsheehan @DanTrifMD Thanks! No association between SRN and eloquent location found. GTV was included in V12, but chiefly small tumors were studied. Individual plans and the sum plan (when available) were assessed, each showing similar conclusions or trends.

@KGergelisMD @MayoRadOnc Thank you so much @KGergelisMD. This wouldn't have been possible without the incredible support from @MayoRadOnc and @dr_kmerrell